Want to join the conversation?
$LGND said approval is based on data from 2 double-blind, randomized, placebo-controlled trials, including largest Phase 3 clinical trial in this patient population. In these studies, patients in treatment and placebo arms were permitted to use some stable maintenance thrombocytopenic purpura (ITP) therapies, per local treatment practices.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.